Promise and Progress of an HIV-1 Cure by Adeno-Associated Virus Vector Delivery of Anti-HIV-1 Biologics

by Matthew R. Gardner
Published 2020-04-01

eCD4-Ig promotes ADCC activity of sera from HIV-1-infected patients.

by Meredith E Davis-Gardner, Matthew R Gardner, Barnett Alfant, Michael Farzan
Published 2017-12-01

A Bispecific Antibody That Simultaneously Recognizes the V2- and V3-Glycan Epitopes of the HIV-1 Envelope Glycoprotein Is Broader and More Potent than Its Parental Antibodies

by Meredith E. Davis-Gardner, Barnett Alfant, Jesse A. Weber, Matthew R. Gardner, Michael Farzan
Published 2020-01-01

HIV-1 inhibitory properties of eCD4-Igmim2 determined using an Env-mediated membrane fusion assay.

by Edward Yang, Matthew R Gardner, Amber S Zhou, Michael Farzan, Ann M Arvin, Stefan L Oliver
Published 2018-01-01

A pentameric protein ring with novel architecture is required for herpesviral packaging

by Allison L Didychuk, Stephanie N Gates, Matthew R Gardner, Lisa M Strong, Andreas Martin, Britt A Glaunsinger
Published 2021-02-01

Diverse pathways of escape from all well-characterized VRC01-class broadly neutralizing HIV-1 antibodies.

by Yuka Otsuka, Kimberly Schmitt, Brian D Quinlan, Matthew R Gardner, Barnett Alfant, Adrian Reich, Michael Farzan, Hyeryun Choe
Published 2018-08-01

Mutations derived from horseshoe bat ACE2 orthologs enhance ACE2-Fc neutralization of SARS-CoV-2.

by Huihui Mou, Brian D Quinlan, Haiyong Peng, Guanqun Liu, Yan Guo, Shoujiao Peng, Lizhou Zhang, Meredith E Davis-Gardner, Matthew R Gardner, Gogce Crynen, Lindsey B DeVaux, Zhi Xiang Voo, Charles C Bailey, Michael D Alpert, Christoph Rader, Michaela U Gack, Hyeryun Choe, Michael Farzan
Published 2021-04-01